Morita A, Takahashi H, Ozawa K, Imafuku S, et al. Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results. J Dermatol 2021;48:3-13.
PMID: 33029861